Net earnings for the first quarter were $209.6 million, a slight increase over the first period of 2011. Operating cash flow during the first quarter was $207.4 million.
The company reported 1 percent growth in both the American and European markets, along with a 10 percent growth in the Asia Pacific market. Total knee and hip sales each jumped 2 percent to $471 million and $344 million, respectively. The reconstructive market was also up 2 percent to $860 million.
However, the company’s spine business dropped 7 percent to $53 million.
More Articles on Orthopedic Devices:
Johnson & Johnson’s New CEO Speaks of Change
AlloSource Hires Dale Binke as Vice President of Marketing & Sales
LDR Holdings Appoints Robert McNamara CFO
